A detailed history of Cwm, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Cwm, LLC holds 17,789 shares of BAX stock, worth $640,226. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,789
Previous 14,831 19.94%
Holding current value
$640,226
Previous $496,000 36.09%
% of portfolio
0.0%
Previous 0.0%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$32.85 - $40.26 $97,170 - $119,089
2,958 Added 19.94%
17,789 $675,000
Q2 2024

Jul 09, 2024

BUY
$32.87 - $43.55 $65,148 - $86,316
1,982 Added 15.43%
14,831 $496,000
Q1 2024

Apr 05, 2024

BUY
$37.88 - $43.77 $113,033 - $130,609
2,984 Added 30.25%
12,849 $549,000
Q4 2023

Feb 01, 2024

SELL
$31.71 - $38.95 $124,049 - $152,372
-3,912 Reduced 28.4%
9,865 $381,000
Q3 2023

Oct 11, 2023

SELL
$37.32 - $49.29 $90,986 - $120,169
-2,438 Reduced 15.04%
13,777 $520,000
Q2 2023

Aug 03, 2023

BUY
$39.98 - $47.68 $72,563 - $86,539
1,815 Added 12.6%
16,215 $739,000
Q1 2023

Apr 28, 2023

BUY
$37.58 - $52.57 $10,409 - $14,561
277 Added 1.96%
14,400 $584,000
Q4 2022

Feb 01, 2023

SELL
$49.7 - $57.71 $203,869 - $236,726
-4,102 Reduced 22.51%
14,123 $720,000
Q3 2022

Oct 27, 2022

BUY
$53.86 - $66.8 $512,854 - $636,069
9,522 Added 109.41%
18,225 $982,000
Q2 2022

Jul 28, 2022

BUY
$63.83 - $80.0 $33,127 - $41,520
519 Added 6.34%
8,703 $559,000
Q1 2022

Apr 21, 2022

BUY
$76.85 - $89.45 $42,190 - $49,108
549 Added 7.19%
8,184 $635,000
Q4 2021

Jan 31, 2022

SELL
$74.57 - $87.19 $35,197 - $41,153
-472 Reduced 5.82%
7,635 $655,000
Q1 2021

Sep 15, 2021

BUY
$76.38 - $86.03 $35,974 - $40,520
471 Added 6.17%
8,107 $653,000
Q1 2021

Apr 27, 2021

SELL
$76.38 - $86.03 $35,974 - $40,520
-471 Reduced 5.81%
7,636 $644,000
Q4 2020

Sep 15, 2021

BUY
$75.39 - $82.36 $124,845 - $136,388
1,656 Added 25.67%
8,107 $653,000
Q4 2020

Jan 27, 2021

SELL
$75.39 - $82.36 $124,845 - $136,388
-1,656 Reduced 20.43%
6,451 $518,000
Q3 2020

Sep 15, 2021

BUY
$78.33 - $90.73 $5,326 - $6,169
68 Added 0.85%
8,107 $653,000
Q3 2020

Oct 19, 2020

SELL
$78.33 - $90.73 $5,326 - $6,169
-68 Reduced 0.84%
8,039 $646,000
Q2 2020

Sep 15, 2021

BUY
$78.66 - $94.14 $370,252 - $443,116
4,707 Added 138.44%
8,107 $653,000
Q2 2020

Jul 22, 2020

SELL
$78.66 - $94.14 $370,252 - $443,116
-4,707 Reduced 58.06%
3,400 $293,000
Q1 2020

Sep 15, 2021

BUY
$71.57 - $93.3 $355,631 - $463,607
4,969 Added 158.35%
8,107 $653,000
Q1 2020

Apr 28, 2020

SELL
$71.57 - $93.3 $355,631 - $463,607
-4,969 Reduced 61.29%
3,138 $255,000
Q4 2019

Sep 14, 2021

BUY
$76.7 - $88.45 $354,430 - $408,727
4,621 Added 132.56%
8,107 $653,000
Q4 2019

Jan 27, 2020

SELL
$76.7 - $88.45 $354,430 - $408,727
-4,621 Reduced 57.0%
3,486 $291,000
Q3 2019

Sep 14, 2021

BUY
$81.4 - $89.78 $460,154 - $507,526
5,653 Added 230.36%
8,107 $653,000
Q3 2019

Oct 22, 2019

SELL
$81.4 - $89.78 $460,154 - $507,526
-5,653 Reduced 69.73%
2,454 $215,000
Q2 2019

Sep 14, 2021

BUY
$73.44 - $82.41 $430,872 - $483,499
5,867 Added 261.92%
8,107 $653,000
Q2 2019

Jul 31, 2019

SELL
$73.44 - $82.41 $430,872 - $483,499
-5,867 Reduced 72.37%
2,240 $183,000
Q1 2019

Sep 02, 2021

BUY
$64.48 - $81.31 $420,151 - $529,815
6,516 Added 409.55%
8,107 $0
Q1 2019

Apr 22, 2019

SELL
$64.48 - $81.31 $2,192 - $2,764
-34 Reduced 2.09%
1,591 $129,000
Q4 2018

Jan 25, 2019

BUY
$61.45 - $77.8 $33,613 - $42,556
547 Added 50.74%
1,625 $107,000
Q3 2018

Oct 29, 2018

BUY
$70.71 - $77.75 $8,060 - $8,863
114 Added 11.83%
1,078 $83,000
Q2 2018

Jul 31, 2018

BUY
$63.43 - $75.41 $1,776 - $2,111
28 Added 2.99%
964 $71,000
Q4 2017

Jan 16, 2018

SELL
$61.45 - $66.05 $1,659 - $1,783
-27 Reduced 2.8%
936 $61,000
Q3 2017

Oct 16, 2017

BUY
$59.5 - $64.61 $57,298 - $62,219
963
963 $60,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18.1B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.